Low-dose Warfarin Functions as an Immunomodulator to Prevent Cyclophosphamide-induced NOD Diabetes
スポンサーリンク
概要
- 論文の詳細を見る
Warfarin has been used as an anticoagulant for a long time. Recently, thepleiotropic effect of warfarin has been investigated. As low-dose warfarin has beenreported to have anti-inflammatory effect through suppression of IL-6 secretion andinhibit the immune-associated signal between Tyro3 and its ligand, Gas6, the effect oflow-dose warfarin on autoimmune diabetes in NOD mice was examined. To investigatethe anti-inflammatory effect of warfarin, IL-6 secretion by splenocytes was examined inthe presence of various concentrations of warfarin. Low concentration of warfarininhibited IL-6 secretion. mRNA expression of Rse, one of the Tyro3 receptor familymembers, and Gas6 were analyzed in NOD mice. It was detected in islets, splenocytesand bone-marrow derived dendritic cells. 0.25 mg/l or 0.50 mg/l of warfarin was orallyadministered to NOD mice as a cyclophosphamide-induced diabetes model. Oraladministration of warfarin at much lower doses than those clinically used as ananticoagulant significantly reduced the degree of insulitis and diabetes incidence in thismodel. We previously demonstrated that anti-FasL Ab-treatment led to completeprevention of autoimmune diabetes in NOD mice. As Fas/FasL signaling is reported tobe essential for cyclophosphamide-induced diabetes model, we extracted RNA fromlymphocytes of the inguinal lymph nodes of anti-FasL Ab-treated NOD mice andperformed real-time PCR to determine expression of Rse gene. Interestingly, theexpression of Rse gene related to the blockade of Fas/FasL signaling was reduced to lessthan half the level of untreated mice. In conclusion, low-dose warfarin is a potentialimmunomodulator which can prevent autoimmune diabetes.
- 神戸大学医学部の論文
- 2008-00-00
神戸大学医学部 | 論文
- 人工弁置換術後死亡例の病理組織学的研究
- 実験的中枢性潰瘍における胃十二指腸粘膜アミンの動態
- 化学発癌剤の染色体レベルでの作用
- 赤血球代謝よりみた高令者術後管理に関する検討--特に2,3-DPG低下防止策について
- Minnesota Impedance Cardiographyに関する研究--波形分析の臨床的評価